European Journal of Cancer
Volume 39, Issue 3 , Pages 353-357, February 2003

The activity of raltitrexed (Tomudex®) in malignant pleural mesothelioma:

an EORTC phase II study (08992)

  • P. Baas

      Affiliations

    • The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author
    • ,
  • A. Ardizzoni

      Affiliations

    • Instituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
    • ,
  • F. Grossi

      Affiliations

    • Universita degli Studi di Udine, Udine, Italy
    • ,
  • K. Nackaerts

      Affiliations

    • University Hospital Gasthuisberg, Belgium
    • ,
  • G. Numico

      Affiliations

    • Ospedale Santa Croce, Cuneo, Italy
    • ,
  • E. Van Marck

      Affiliations

    • University of Antwerp, Dept of Pathology, Antwerp, Belgium
    • ,
  • M. van de Vijver

      Affiliations

    • The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • F. Monetti

      Affiliations

    • Instituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
    • ,
  • M.J.A. Smid-Geirnaerdt

      Affiliations

    • Stichting Oosterschelde Ziekenhuizen, Goes, The Netherlands
    • ,
  • N. van Zandwijk

      Affiliations

    • The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • C. Debruyne

      Affiliations

    • The EORTC Data Center, Brussels, Belgium
    • ,
  • C. Legrand

      Affiliations

    • The EORTC Data Center, Brussels, Belgium
    • ,
  • G. Giaccone

      Affiliations

    • Academisch Ziekenhuis der Vrije Universiteit, Amsterdam, The Netherlands
    • ,
  • on behalf of the EORTC Lung Cancer Group

Received 15 October 2002; accepted 16 October 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(02)00668-8

European Journal of Cancer
Volume 39, Issue 3 , Pages 353-357, February 2003

Article Tools